1,2-dimethylhydrazine increases expression ISO Bub1b (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in increased expression of BUB1B mRNA CTD PMID:22206623 1-chloro-2,4-dinitrobenzene increases expression ISO Bub1b (Mus musculus) 6480464 Dinitrochlorobenzene results in increased expression of BUB1B mRNA CTD PMID:21404309 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of BUB1B mRNA CTD PMID:30723492 17alpha-ethynylestradiol increases expression ISO Bub1b (Mus musculus) 6480464 Ethinyl Estradiol results in increased expression of BUB1B mRNA CTD PMID:17942748 17alpha-ethynylestradiol multiple interactions ISO Bub1b (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of BUB1B mRNA CTD PMID:17942748 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of BUB1B mRNA CTD PMID:17351261 17beta-estradiol affects expression ISO Bub1b (Mus musculus) 6480464 Estradiol affects the expression of BUB1B mRNA CTD PMID:15721199 17beta-estradiol multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of BUB1B mRNA CTD PMID:32741896 17beta-estradiol affects expression EXP 6480464 Estradiol affects the expression of BUB1B mRNA CTD PMID:32145629 17beta-estradiol increases expression ISO Bub1b (Mus musculus) 6480464 Estradiol results in increased expression of BUB1B mRNA CTD PMID:19484750 17beta-estradiol increases expression ISO BUB1B (Homo sapiens) 6480464 Estradiol results in increased expression of BUB1B mRNA CTD PMID:16474171 and PMID:19167446 17beta-estradiol 3-benzoate multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of BUB1B mRNA CTD PMID:32741896 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO Bub1b (Mus musculus) 6480464 Dihydrotestosterone results in increased expression of BUB1B mRNA CTD PMID:17023530 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO Bub1b (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO Bub1b (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Bub1b (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of BUB1B mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of BUB1B mRNA CTD PMID:32109520 and PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Bub1b (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of BUB1B mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of BUB1B mRNA CTD PMID:22298810 2,3-dimethoxynaphthalene-1,4-dione increases expression ISO BUB1B (Homo sapiens) 6480464 2 more ... CTD PMID:19031421 2-palmitoylglycerol increases expression ISO BUB1B (Homo sapiens) 6480464 2-palmitoylglycerol results in increased expression of BUB1B mRNA CTD PMID:37199045 3-methylcholanthrene increases expression ISO Bub1b (Mus musculus) 6480464 Methylcholanthrene results in increased expression of BUB1B mRNA CTD PMID:20713471 4-(ethoxymethylene)-2-phenyloxazol-5-one increases expression ISO Bub1b (Mus musculus) 6480464 Oxazolone results in increased expression of BUB1B mRNA CTD PMID:21404309 4-hydroxynon-2-enal decreases expression ISO Bub1b (Mus musculus) 6480464 4-hydroxy-2-nonenal results in decreased expression of BUB1B mRNA CTD PMID:19191707 5-aza-2'-deoxycytidine multiple interactions ISO BUB1B (Homo sapiens) 6480464 Decitabine inhibits the reaction [HDAC1 protein binds to BUB1B promoter] and Decitabine inhibits the reaction [MBD2 protein binds to BUB1B promoter] CTD PMID:17464181 5-aza-2'-deoxycytidine affects expression ISO BUB1B (Homo sapiens) 6480464 Decitabine affects the expression of BUB1B mRNA CTD PMID:23300844 5-azacytidine multiple interactions ISO BUB1B (Homo sapiens) 6480464 [Azacitidine co-treated with Thalidomide] affects the expression of BUB1B mRNA CTD PMID:18720364 5-fluorouracil decreases expression ISO BUB1B (Homo sapiens) 6480464 Fluorouracil results in decreased expression of BUB1B mRNA CTD PMID:16557594 and PMID:16709241 5-fluorouracil decreases expression ISO Bub1b (Mus musculus) 6480464 Fluorouracil results in decreased expression of BUB1B mRNA CTD PMID:19272435 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of BUB1B mRNA CTD PMID:24780913 and PMID:30047161 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of BUB1B mRNA CTD PMID:25825206 acetamide increases expression EXP 6480464 acetamide results in increased expression of BUB1B mRNA CTD PMID:31881176 acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of BUB1B mRNA CTD PMID:28959563 aflatoxin B1 affects expression ISO BUB1B (Homo sapiens) 6480464 Aflatoxin B1 affects the expression of BUB1B protein CTD PMID:20106945 aflatoxin B1 decreases expression ISO Bub1b (Mus musculus) 6480464 Aflatoxin B1 results in decreased expression of BUB1B mRNA CTD PMID:19770486 aflatoxin M1 decreases expression ISO BUB1B (Homo sapiens) 6480464 Aflatoxin M1 results in decreased expression of BUB1B mRNA CTD PMID:30928695 all-trans-retinoic acid decreases expression ISO BUB1B (Homo sapiens) 6480464 Tretinoin results in decreased expression of BUB1B mRNA CTD PMID:33167477 amitrole increases expression EXP 6480464 Amitrole results in increased expression of BUB1B mRNA CTD PMID:30047161 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of BUB1B mRNA CTD PMID:16483693 amphetamine decreases expression EXP 6480464 Amphetamine results in decreased expression of BUB1B mRNA CTD PMID:30779732 aristolochic acid A decreases expression ISO BUB1B (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of BUB1B mRNA CTD PMID:33212167 arsenite(3-) multiple interactions ISO BUB1B (Homo sapiens) 6480464 arsenite inhibits the reaction [G3BP1 protein binds to BUB1B mRNA] CTD PMID:32406909 arsenous acid multiple interactions ISO BUB1B (Homo sapiens) 6480464 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin promotes the reaction [Arsenic Trioxide results in increased phosphorylation of BUB1B protein] more ... CTD PMID:19371599 and PMID:19781537 arsenous acid increases phosphorylation ISO BUB1B (Homo sapiens) 6480464 Arsenic Trioxide results in increased phosphorylation of BUB1B protein CTD PMID:19371599 atrazine increases expression ISO BUB1B (Homo sapiens) 6480464 Atrazine results in increased expression of BUB1B mRNA CTD PMID:18585445 azathioprine decreases expression ISO BUB1B (Homo sapiens) 6480464 Azathioprine results in decreased expression of BUB1B mRNA CTD PMID:22623647 benomyl increases expression ISO BUB1B (Homo sapiens) 6480464 Benomyl results in increased expression of BUB1B protein CTD PMID:16903866 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of BUB1B mRNA CTD PMID:21839799 benzo[a]pyrene decreases expression ISO BUB1B (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of BUB1B mRNA CTD PMID:16120219 and PMID:20064835 benzo[a]pyrene decreases expression ISO Bub1b (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of BUB1B mRNA CTD PMID:19770486 benzo[a]pyrene increases expression ISO Bub1b (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of BUB1B mRNA CTD PMID:20713471 and PMID:32417428 benzo[a]pyrene diol epoxide I decreases expression ISO BUB1B (Homo sapiens) 6480464 7 more ... CTD PMID:19150397 and PMID:20382639 bicalutamide decreases expression ISO BUB1B (Homo sapiens) 6480464 bicalutamide results in decreased expression of BUB1B mRNA CTD PMID:15638997 bisphenol A increases expression ISO BUB1B (Homo sapiens) 6480464 bisphenol A results in increased expression of BUB1B mRNA CTD PMID:16474171 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of BUB1B mRNA CTD PMID:32145629 bisphenol A affects localization ISO BUB1B (Homo sapiens) 6480464 bisphenol A affects the localization of BUB1B protein CTD PMID:30980863 bisphenol A decreases expression ISO BUB1B (Homo sapiens) 6480464 bisphenol A results in decreased expression of BUB1B mRNA and bisphenol A results in decreased expression of BUB1B protein CTD PMID:27979917 more ... bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of BUB1B mRNA CTD PMID:26982218 more ... Bisphenol A diglycidyl ether affects splicing ISO Bub1b (Mus musculus) 6480464 2 and 2-bis(4-glycidyloxyphenyl)propane affects the splicing of BUB1B mRNA CTD PMID:36464114 Bisphenol B increases expression ISO Bub1b (Mus musculus) 6480464 bisphenol B results in increased expression of BUB1B protein CTD PMID:33392205 bisphenol F affects expression ISO Bub1b (Mus musculus) 6480464 bisphenol F affects the expression of BUB1B mRNA CTD PMID:35387338 butanal decreases expression ISO BUB1B (Homo sapiens) 6480464 butyraldehyde results in decreased expression of BUB1B mRNA CTD PMID:26079696 cadmium atom decreases expression ISO BUB1B (Homo sapiens) 6480464 Cadmium results in decreased expression of BUB1B mRNA CTD PMID:21120746 caffeine decreases phosphorylation ISO BUB1B (Homo sapiens) 6480464 Caffeine results in decreased phosphorylation of BUB1B protein CTD PMID:35688186 calcitriol decreases expression ISO BUB1B (Homo sapiens) 6480464 Calcitriol results in decreased expression of BUB1B mRNA CTD PMID:21592394 calcitriol multiple interactions ISO BUB1B (Homo sapiens) 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of BUB1B mRNA CTD PMID:21592394 cannabidiol decreases expression ISO BUB1B (Homo sapiens) 6480464 Cannabidiol results in decreased expression of BUB1B mRNA CTD PMID:36519830 carbamazepine affects expression ISO BUB1B (Homo sapiens) 6480464 Carbamazepine affects the expression of BUB1B mRNA CTD PMID:25979313 carbendazim increases activity ISO Bub1b (Mus musculus) 6480464 carbendazim results in increased activity of BUB1B protein CTD PMID:37506866 carbon nanotube increases expression ISO Bub1b (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 cefaloridine decreases expression EXP 6480464 Cephaloridine results in decreased expression of BUB1B mRNA CTD PMID:18500788 CGP 52608 multiple interactions ISO BUB1B (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to BUB1B gene] CTD PMID:28238834 chlorpyrifos decreases expression ISO Bub1b (Mus musculus) 6480464 Chlorpyrifos results in decreased expression of BUB1B mRNA CTD PMID:37019170 choline affects expression ISO BUB1B (Homo sapiens) 6480464 Choline affects the expression of BUB1B mRNA CTD PMID:17616785 choline multiple interactions ISO Bub1b (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of BUB1B mRNA CTD PMID:20938992 chromium(6+) decreases expression ISO BUB1B (Homo sapiens) 6480464 chromium hexavalent ion results in decreased expression of BUB1B protein CTD PMID:22886373 chromium(6+) multiple interactions ISO BUB1B (Homo sapiens) 6480464 pifithrin inhibits the reaction [TP53 protein promotes the reaction [chromium hexavalent ion results in decreased expression of BUB1B protein]] and TP53 protein promotes the reaction [chromium hexavalent ion results in decreased expression of BUB1B protein] CTD PMID:22886373 cisplatin multiple interactions ISO BUB1B (Homo sapiens) 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of BUB1B mRNA and Cisplatin inhibits the reaction [Piroxicam results in decreased expression of BUB1B mRNA] CTD PMID:21858171 and PMID:27392435 cisplatin affects expression ISO BUB1B (Homo sapiens) 6480464 Cisplatin affects the expression of BUB1B mRNA CTD PMID:23300844 cisplatin increases expression ISO Bub1b (Mus musculus) 6480464 Cisplatin results in increased expression of BUB1B mRNA CTD PMID:21151649 copper atom multiple interactions ISO BUB1B (Homo sapiens) 6480464 [Chelating Agents binds to Copper] which results in decreased expression of BUB1B mRNA and [NSC 689534 binds to Copper] which results in decreased expression of BUB1B mRNA CTD PMID:20971185 and PMID:30911355 copper(0) multiple interactions ISO BUB1B (Homo sapiens) 6480464 [Chelating Agents binds to Copper] which results in decreased expression of BUB1B mRNA and [NSC 689534 binds to Copper] which results in decreased expression of BUB1B mRNA CTD PMID:20971185 and PMID:30911355 copper(II) sulfate decreases expression ISO BUB1B (Homo sapiens) 6480464 Copper Sulfate results in decreased expression of BUB1B mRNA CTD PMID:19549813 coumestrol multiple interactions ISO BUB1B (Homo sapiens) 6480464 [Coumestrol co-treated with 2 more ... CTD PMID:19167446 coumestrol increases expression ISO BUB1B (Homo sapiens) 6480464 Coumestrol results in increased expression of BUB1B mRNA CTD PMID:19167446 cryptolepine decreases expression ISO BUB1B (Homo sapiens) 6480464 cryptolepine results in decreased expression of BUB1B mRNA CTD PMID:16120219 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of BUB1B mRNA CTD PMID:26577399 cyclosporin A decreases expression ISO BUB1B (Homo sapiens) 6480464 Cyclosporine results in decreased expression of BUB1B mRNA CTD PMID:20106945 more ... cyclosporin A increases methylation ISO BUB1B (Homo sapiens) 6480464 Cyclosporine results in increased methylation of BUB1B promoter CTD PMID:27989131 daidzein affects expression ISO Bub1b (Mus musculus) 6480464 daidzein affects the expression of BUB1B mRNA CTD PMID:15721199 deoxynivalenol increases expression ISO BUB1B (Homo sapiens) 6480464 deoxynivalenol results in increased expression of BUB1B mRNA CTD PMID:31863870 diarsenic trioxide multiple interactions ISO BUB1B (Homo sapiens) 6480464 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin promotes the reaction [Arsenic Trioxide results in increased phosphorylation of BUB1B protein] more ... CTD PMID:19371599 and PMID:19781537 diarsenic trioxide increases phosphorylation ISO BUB1B (Homo sapiens) 6480464 Arsenic Trioxide results in increased phosphorylation of BUB1B protein CTD PMID:19371599 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of BUB1B mRNA CTD PMID:21266533 dibutyl phthalate multiple interactions ISO BUB1B (Homo sapiens) 6480464 N-methyl-delta-3 more ... CTD PMID:36828243 dibutyl phthalate increases expression ISO BUB1B (Homo sapiens) 6480464 Dibutyl Phthalate results in increased expression of BUB1B mRNA CTD PMID:36828243 dibutyl phthalate decreases expression ISO BUB1B (Homo sapiens) 6480464 Dibutyl Phthalate results in decreased expression of BUB1B mRNA CTD PMID:28973377 dibutyl phthalate decreases expression ISO Bub1b (Mus musculus) 6480464 Dibutyl Phthalate results in decreased expression of BUB1B mRNA CTD PMID:21266533 dichloroacetic acid increases expression ISO Bub1b (Mus musculus) 6480464 Dichloroacetic Acid results in increased expression of BUB1B mRNA CTD PMID:28962523 diethylstilbestrol affects expression ISO Bub1b (Mus musculus) 6480464 Diethylstilbestrol affects the expression of BUB1B mRNA CTD PMID:15721199 dioxygen decreases expression ISO BUB1B (Homo sapiens) 6480464 Oxygen deficiency results in decreased expression of BUB1B mRNA CTD PMID:26516004 dioxygen multiple interactions EXP 6480464 [dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of BUB1B mRNA] and [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of BUB1B mRNA CTD PMID:33729688 doxorubicin affects response to substance ISO BUB1B (Homo sapiens) 6480464 BUB1B protein affects the susceptibility to Doxorubicin CTD PMID:16217747 doxorubicin decreases expression ISO BUB1B (Homo sapiens) 6480464 Doxorubicin results in decreased expression of BUB1B mRNA and Doxorubicin results in decreased expression of BUB1B protein CTD PMID:15870702 more ... Enterolactone multiple interactions ISO BUB1B (Homo sapiens) 6480464 [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BUB1B mRNA CTD PMID:19167446 epoxiconazole increases expression ISO Bub1b (Mus musculus) 6480464 epoxiconazole results in increased expression of BUB1B mRNA CTD PMID:35436446 etoposide decreases expression ISO BUB1B (Homo sapiens) 6480464 Etoposide results in decreased expression of BUB1B mRNA CTD PMID:16120219 folic acid multiple interactions ISO Bub1b (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of BUB1B mRNA CTD PMID:20938992 folic acid multiple interactions ISO BUB1B (Homo sapiens) 6480464 [Folic Acid deficiency co-treated with Methotrexate] results in decreased expression of BUB1B mRNA CTD PMID:24657277 formaldehyde decreases expression ISO BUB1B (Homo sapiens) 6480464 Formaldehyde results in decreased expression of BUB1B mRNA CTD PMID:23649840 FR900359 decreases phosphorylation ISO BUB1B (Homo sapiens) 6480464 FR900359 results in decreased phosphorylation of BUB1B protein CTD PMID:37730182 fulvestrant multiple interactions ISO BUB1B (Homo sapiens) 6480464 [fulvestrant co-treated with Sirolimus] results in decreased expression of BUB1B mRNA CTD PMID:19016759 fulvestrant decreases expression ISO BUB1B (Homo sapiens) 6480464 fulvestrant results in decreased expression of BUB1B mRNA CTD PMID:19016759 genistein increases expression ISO BUB1B (Homo sapiens) 6480464 Genistein results in increased expression of BUB1B mRNA CTD PMID:16474171 genistein affects expression ISO BUB1B (Homo sapiens) 6480464 Genistein affects the expression of BUB1B mRNA CTD PMID:18847459 geraniol decreases expression ISO BUB1B (Homo sapiens) 6480464 geraniol results in decreased expression of BUB1B mRNA CTD PMID:27683099 glycidol decreases expression EXP 6480464 glycidol results in decreased expression of BUB1B mRNA CTD PMID:24395379 GW 3965 decreases expression ISO BUB1B (Homo sapiens) 6480464 GW 3965 results in decreased expression of BUB1B mRNA CTD PMID:31437187 GW 4064 increases expression ISO BUB1B (Homo sapiens) 6480464 GW 4064 results in increased expression of BUB1B mRNA CTD PMID:31437187 ketamine decreases expression EXP 6480464 Ketamine results in decreased expression of BUB1B mRNA CTD PMID:20080153 L-methionine multiple interactions ISO Bub1b (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of BUB1B mRNA CTD PMID:20938992 leflunomide decreases expression ISO BUB1B (Homo sapiens) 6480464 leflunomide results in decreased expression of BUB1B mRNA CTD PMID:28988120 lidocaine increases expression EXP 6480464 Lidocaine results in increased expression of BUB1B mRNA CTD PMID:35283115 lithium atom increases expression EXP 6480464 Lithium results in increased expression of BUB1B mRNA CTD PMID:21711903 lithium hydride increases expression EXP 6480464 Lithium results in increased expression of BUB1B mRNA CTD PMID:21711903 lucanthone decreases expression ISO BUB1B (Homo sapiens) 6480464 Lucanthone results in decreased expression of BUB1B mRNA CTD PMID:21148553 metformin affects expression ISO BUB1B (Homo sapiens) 6480464 Metformin affects the expression of BUB1B mRNA CTD PMID:35568294 methamphetamine decreases expression EXP 6480464 Methamphetamine results in decreased expression of BUB1B mRNA CTD PMID:28341135 methimazole increases expression EXP 6480464 Methimazole results in increased expression of BUB1B mRNA CTD PMID:30047161 methotrexate multiple interactions ISO BUB1B (Homo sapiens) 6480464 [Folic Acid deficiency co-treated with Methotrexate] results in decreased expression of BUB1B mRNA CTD PMID:24657277 methotrexate decreases expression ISO BUB1B (Homo sapiens) 6480464 Methotrexate results in decreased expression of BUB1B mRNA CTD PMID:24657277 methylseleninic acid affects expression ISO BUB1B (Homo sapiens) 6480464 methylselenic acid affects the expression of BUB1B mRNA CTD PMID:14617803 N-methyl-4-phenylpyridinium decreases expression ISO Bub1b (Mus musculus) 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of BUB1B protein CTD PMID:26558463 N-Nitrosopyrrolidine decreases expression ISO BUB1B (Homo sapiens) 6480464 N-Nitrosopyrrolidine results in decreased expression of BUB1B mRNA CTD PMID:32234424 nickel atom increases expression ISO BUB1B (Homo sapiens) 6480464 Nickel results in increased expression of BUB1B mRNA CTD PMID:19031421 and PMID:25583101 ochratoxin A increases expression EXP 6480464 ochratoxin A results in increased expression of BUB1B mRNA CTD PMID:19237604 oxaliplatin decreases expression EXP 6480464 oxaliplatin results in decreased expression of BUB1B mRNA CTD PMID:25729387 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of BUB1B mRNA CTD PMID:25729387 ozone decreases expression ISO Bub1b (Mus musculus) 6480464 Ozone results in decreased expression of BUB1B mRNA CTD PMID:24336422 ozone multiple interactions ISO Bub1b (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of BUB1B mRNA more ... CTD PMID:25658374 more ... paclitaxel multiple interactions ISO BUB1B (Homo sapiens) 6480464 [arsenic trioxide co-treated with Paclitaxel] promotes the reaction [BUB1B protein binds to CDC20 protein] and [arsenic trioxide co-treated with Paclitaxel] results in increased expression of BUB1B protein modified form CTD PMID:19781537 paclitaxel affects response to substance ISO BUB1B (Homo sapiens) 6480464 BUB1B protein affects the susceptibility to Paclitaxel CTD PMID:18691855 paracetamol increases expression ISO BUB1B (Homo sapiens) 6480464 Acetaminophen results in increased expression of BUB1B mRNA CTD PMID:22230336 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of BUB1B mRNA CTD PMID:33387578 paracetamol decreases expression ISO BUB1B (Homo sapiens) 6480464 Acetaminophen results in decreased expression of BUB1B mRNA CTD PMID:29067470 paraquat multiple interactions ISO Bub1b (Mus musculus) 6480464 [ATG7 protein affects the susceptibility to Paraquat] which affects the expression of BUB1B mRNA CTD PMID:28012437 PCB138 multiple interactions ISO Bub1b (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 perfluorodecanoic acid affects localization ISO Bub1b (Mus musculus) 6480464 perfluorodecanoic acid affects the localization of BUB1B protein CTD PMID:34358620 perfluorooctanoic acid decreases expression ISO BUB1B (Homo sapiens) 6480464 perfluorooctanoic acid results in decreased expression of BUB1B mRNA CTD PMID:36326898 phenethyl isothiocyanate decreases expression ISO BUB1B (Homo sapiens) 6480464 phenethyl isothiocyanate results in decreased expression of BUB1B mRNA CTD PMID:26678675 phenobarbital increases expression ISO Bub1b (Mus musculus) 6480464 Phenobarbital results in increased expression of BUB1B mRNA CTD PMID:19363144 and PMID:23091169 phenylmercury acetate affects response to substance ISO BUB1B (Homo sapiens) 6480464 BUB1B gene SNP affects the susceptibility to Phenylmercuric Acetate CTD PMID:25622337 PhIP increases expression ISO BUB1B (Homo sapiens) 6480464 2-amino-1-methyl-6-phenylimidazo(4 and 5-b)pyridine results in increased expression of BUB1B mRNA CTD PMID:16120219 phorbol 13-acetate 12-myristate increases expression ISO BUB1B (Homo sapiens) 6480464 Tetradecanoylphorbol Acetate results in increased expression of BUB1B mRNA CTD PMID:19031421 phytoestrogen affects expression ISO Bub1b (Mus musculus) 6480464 Phytoestrogens affects the expression of BUB1B mRNA CTD PMID:15721199 picoxystrobin increases expression ISO BUB1B (Homo sapiens) 6480464 picoxystrobin results in increased expression of BUB1B mRNA CTD PMID:33512557 Piplartine decreases expression ISO Bub1b (Mus musculus) 27372888 Piplartine decreases expression of BUB1B mRNA in B cells RGD pirinixic acid increases expression ISO Bub1b (Mus musculus) 6480464 pirinixic acid results in increased expression of BUB1B mRNA CTD PMID:18301758 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of BUB1B mRNA CTD PMID:19162173 pirinixic acid multiple interactions ISO BUB1B (Homo sapiens) 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of BUB1B mRNA CTD PMID:19710929 piroxicam multiple interactions ISO BUB1B (Homo sapiens) 6480464 Cisplatin inhibits the reaction [Piroxicam results in decreased expression of BUB1B mRNA] CTD PMID:21858171 piroxicam decreases expression ISO BUB1B (Homo sapiens) 6480464 Piroxicam results in decreased expression of BUB1B mRNA CTD PMID:21858171 pravastatin affects expression ISO Bub1b (Mus musculus) 6480464 Pravastatin affects the expression of BUB1B mRNA CTD PMID:27225895 pravastatin decreases expression EXP 6480464 Pravastatin results in decreased expression of BUB1B mRNA CTD PMID:27225895 pregnenolone 16alpha-carbonitrile increases expression EXP 6480464 Pregnenolone Carbonitrile results in increased expression of BUB1B mRNA CTD PMID:30047161 progesterone decreases expression ISO BUB1B (Homo sapiens) 6480464 Progesterone results in decreased expression of BUB1B mRNA CTD PMID:21795739 propanal decreases expression ISO BUB1B (Homo sapiens) 6480464 propionaldehyde results in decreased expression of BUB1B mRNA CTD PMID:26079696 quercetin increases expression ISO BUB1B (Homo sapiens) 6480464 Quercetin results in increased expression of BUB1B mRNA CTD PMID:15309432 quercetin decreases expression ISO BUB1B (Homo sapiens) 6480464 Quercetin results in decreased expression of BUB1B mRNA CTD PMID:21632981 and PMID:23727915 resveratrol decreases expression ISO BUB1B (Homo sapiens) 6480464 resveratrol results in decreased expression of BUB1B mRNA and resveratrol results in decreased expression of BUB1B protein CTD PMID:15767336 and PMID:18089832 resveratrol increases expression ISO BUB1B (Homo sapiens) 6480464 resveratrol results in increased expression of BUB1B mRNA CTD PMID:19167446 resveratrol multiple interactions ISO BUB1B (Homo sapiens) 6480464 [Coumestrol co-treated with resveratrol] results in increased expression of BUB1B mRNA CTD PMID:19167446 rotenone multiple interactions ISO BUB1B (Homo sapiens) 6480464 Rotenone results in increased expression of and affects the localization of BUB1B protein CTD PMID:17697112 rotenone increases expression ISO BUB1B (Homo sapiens) 6480464 Rotenone results in increased expression of BUB1B mRNA CTD PMID:33512557 silicon dioxide affects expression ISO BUB1B (Homo sapiens) 6480464 Silicon Dioxide analog affects the expression of BUB1B mRNA CTD PMID:23806026 silicon dioxide increases expression ISO Bub1b (Mus musculus) 6480464 Silicon Dioxide results in increased expression of BUB1B mRNA CTD PMID:29341224 silver(1+) nitrate increases expression ISO BUB1B (Homo sapiens) 6480464 Silver Nitrate analog results in increased expression of BUB1B mRNA and Silver Nitrate results in increased expression of BUB1B mRNA CTD PMID:22831968 sirolimus multiple interactions ISO BUB1B (Homo sapiens) 6480464 [fulvestrant co-treated with Sirolimus] results in decreased expression of BUB1B mRNA CTD PMID:19016759 sodium arsenite increases expression ISO BUB1B (Homo sapiens) 6480464 sodium arsenite results in increased expression of BUB1B mRNA CTD PMID:29301061 and PMID:34032870 SP2509 decreases expression ISO BUB1B (Homo sapiens) 6480464 SP2509 results in decreased expression of BUB1B mRNA CTD PMID:29581250 staurosporine affects expression ISO Bub1b (Mus musculus) 6480464 Staurosporine affects the expression of BUB1B mRNA CTD PMID:15721199 sulfadimethoxine increases expression EXP 6480464 Sulfadimethoxine results in increased expression of BUB1B mRNA CTD PMID:30047161 sulindac sulfide decreases expression ISO BUB1B (Homo sapiens) 6480464 sulindac sulfide results in decreased expression of BUB1B mRNA CTD PMID:16184548 sunitinib decreases expression ISO BUB1B (Homo sapiens) 6480464 Sunitinib results in decreased expression of BUB1B mRNA CTD PMID:31533062 testosterone multiple interactions ISO BUB1B (Homo sapiens) 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of BUB1B mRNA CTD PMID:21592394 testosterone multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of BUB1B mRNA CTD PMID:32741896 testosterone decreases expression ISO BUB1B (Homo sapiens) 6480464 Testosterone results in decreased expression of BUB1B mRNA CTD PMID:21592394 tetrachloromethane increases expression ISO Bub1b (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of BUB1B mRNA CTD PMID:17484886 and PMID:31919559 thalidomide multiple interactions ISO BUB1B (Homo sapiens) 6480464 [Azacitidine co-treated with Thalidomide] affects the expression of BUB1B mRNA CTD PMID:18720364 thapsigargin decreases expression ISO BUB1B (Homo sapiens) 6480464 Thapsigargin results in decreased expression of BUB1B mRNA CTD PMID:22378314 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of BUB1B mRNA CTD PMID:34492290 titanium dioxide increases expression ISO Bub1b (Mus musculus) 6480464 titanium dioxide results in increased expression of BUB1B mRNA CTD PMID:23557971 titanium dioxide increases expression EXP 6480464 titanium dioxide results in increased expression of BUB1B mRNA CTD PMID:30012374 toluene 2,4-diisocyanate increases expression ISO Bub1b (Mus musculus) 6480464 Toluene 2 and 4-Diisocyanate results in increased expression of BUB1B mRNA CTD PMID:21404309 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of BUB1B mRNA CTD PMID:25729387 topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of BUB1B mRNA CTD PMID:25729387 Tributyltin oxide decreases expression ISO Bub1b (Mus musculus) 6480464 bis(tri-n-butyltin)oxide results in decreased expression of BUB1B mRNA CTD PMID:18958704 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of BUB1B mRNA CTD PMID:33387578 trimellitic anhydride increases expression ISO Bub1b (Mus musculus) 6480464 trimellitic anhydride results in increased expression of BUB1B mRNA CTD PMID:19042947 Triptolide increases expression EXP 6480464 triptolide results in increased expression of BUB1B mRNA CTD PMID:23639586 troglitazone decreases expression ISO BUB1B (Homo sapiens) 6480464 troglitazone results in decreased expression of BUB1B mRNA CTD PMID:19140230 trovafloxacin decreases expression ISO Bub1b (Mus musculus) 6480464 trovafloxacin results in decreased expression of BUB1B mRNA CTD PMID:35537566 tunicamycin decreases expression ISO BUB1B (Homo sapiens) 6480464 Tunicamycin results in decreased expression of BUB1B mRNA CTD PMID:22378314 valproic acid decreases expression ISO Bub1b (Mus musculus) 6480464 Valproic Acid results in decreased expression of BUB1B mRNA CTD PMID:21427059 valproic acid decreases expression ISO BUB1B (Homo sapiens) 6480464 Valproic Acid results in decreased expression of BUB1B mRNA CTD PMID:23179753 and PMID:27188386 zaragozic acid A decreases expression EXP 6480464 squalestatin 1 results in decreased expression of BUB1B mRNA CTD PMID:27225895 zaragozic acid A decreases expression ISO Bub1b (Mus musculus) 6480464 squalestatin 1 results in decreased expression of BUB1B mRNA CTD PMID:27225895